title: [Pneumococcal sepsis in aged patients - implications for the                     vaccination of seniors against pneumococci].
abstract: In the years 2005-2010 pneumococci were isolated in the Limbach                     laboratory/Heidelberg from blood cultures of 1,085 patients. Obviously, older                     patients are more prone to these bacteria, since 66 % of the patients were older                     than 60 years. All isolates were susceptible to cefotaxime; 3 % of isolates were                     resistant to penicillin, 2 % were resistant to levofloxacin and 15 % were                     resistant to erythromycin. From 457 out of the isolates serotyping was achieved:                     more than 80 % of the isolates were covered by the 23-valent vaccine. This means                     that particularly old people should be vaccinated against pneumococci, because                     they will profit probably most from such preventive measurements.
authors: H
authors: H
authors: Hof
authors: K
authors: K
authors: Oberdorfer
authors: S
authors: S
authors: Singer
authors: M
authors: M
authors: Holfelder
authors: A
authors: A
authors: Fahr
mesh_terms: D000367:Age Factors; D000368:Aged; D003430:Cross-Sectional Studies; D004352:Drug Resistance, Microbial; D005858:Germany; D006801:Humans; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000008:administration & dosage*; D012307:Risk Factors; D018805:Sepsis / Q000453:epidemiology / Q000517:prevention & control*; D012703:Serotyping
chemical_list: D022242:Pneumococcal Vaccines